Navigation Links
Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting

ough 36 weeks post-menstrual age (PMA), and

* fewer days on mechanical ventilation.

Dr. Bose commented, "The data from this Phase 2 estimation trial are encouraging. These data support the continued evaluation of Surfaxin as a therapeutic option for the prevention of BPD."

Discovery's Phase 2 clinical trial enrolled 136 premature infants. In addition to standard of care, patients were randomized to receive either Surfaxin standard dose (175 mg/kg), Surfaxin low dose (90 mg/kg), or sham air as a control. The trial was designed as an estimation study to evaluate the safety and potential efficacy of Surfaxin in infants at risk for BPD, and was not powered to determine statistically significant differences in outcomes. The Surfaxin standard dose (175 mg/kg) is the dose that was administered in Discovery's RDS Phase 3 clinical trials. No meaningful conclusions could be drawn from the Surfaxin low dose (90 mg/kg) treatment group, as infants randomized to this arm had more pre-existing medical risk factors compared with the Surfaxin standard dose (175 mg/kg) group and the control group.

Aerosurf(tm) (aerosolized KL-4 surfactant) delivered via the Chrysalis Technologies novel capillary aerosol generator device

Data from previously conducted pre-clinical studies using aerosolized KL-4 surfactant were also presented to the medical community for the first time. In these studies, KL-4 surfactant was aerosolized to compare Chrysalis' novel, investigational capillary aerosol generator technology to commercially available aerosol generator devices. The studies demonstrated that Aerosurf maintains its chemical structure and essential functional activity post-aerosolization. In addition, the Chrysalis investigational capillary aerosol generator technology generated a nearly 10-fold higher aerosol output rate than the other study devices.

Discovery Labs, in collaboration with Chrysalis, is developing an integrated drug device system that comb
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
2. Discoverys KL-4 Surfactant Technology Demonstrates Novel Anti-Inflammatory Properties
3. Major Discovery Raises Prospect of Better Patient Care By Improving Platelet Life Span
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
6. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
7. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
8. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
9. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
10. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
11. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
Post Your Comments:
(Date:9/17/2014)... , Sept. 17, 2014   OTEMR, Inc. ... Edition Complete EHR certification, which designates that the software ... Stage 1 and Stage 2 Meaningful Use measures required ... Reinvestment Act (ARRA).  ONETOUCH EMR 2.0 was certified on ... Office of the National Coordinator-Authorized Certification Body (ONC-ACB) and ...
(Date:9/17/2014)... MUMBAI, India , September 17, 2014 ... TRPA1 antagonist, GRC 17536, has shown positive data in ... with painful diabetic neuropathy , ... Transient Receptor Potential Ankyrin 1 (TRPA1) antagonist, GRC 17536 ... blind, placebo controlled, multi-centre, proof of concept study conducted ...
(Date:9/17/2014)... 17, 2014  Bayer HealthCare will present data on ... th Annual Meeting, which takes place September 18-20 ... which will be shared through poster presentations, showcase Bayer,s ... Data will be presented in a scientific forum. ... in hemophilia A patients, Bayer is maintaining its commitment ...
Breaking Medicine Technology:OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 2OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 3Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study 2Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study 3Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 2Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 3Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 4
... and SAN FRANCISCO , May 31 Dendreon Corporation ... the integrated analysis of four randomized PROVENGE® (sipuleucel-T) clinical trials of an ... of the American Urological Association (AUA) in San Francisco . ... "The approval of PROVENGE ...
... , May 28, 2010 Shire plc (LSE: SHP,NASDAQ: ... Paragraph IV Notice Letter today from Zydus,Pharmaceuticals USA, Inc. ("Zydus") advising of ... of Shire,s 1.2g,mesalamine delayed release tablets, LIALDA(R). , ... LIALDA is protected by the ...
Cached Medicine Technology:Dendreon Announces Presentation of PROVENGE Data at the American Urological Association Annual Meeting 2Dendreon Announces Presentation of PROVENGE Data at the American Urological Association Annual Meeting 3Dendreon Announces Presentation of PROVENGE Data at the American Urological Association Annual Meeting 4Shire Receives LIALDA(R) Paragraph IV Notice Letter From Zydus Pharmaceuticals 2Shire Receives LIALDA(R) Paragraph IV Notice Letter From Zydus Pharmaceuticals 3
(Date:9/17/2014)... September 17, 2014 The global metrology ... worth due to the key driving factors of increasing ... expected CAGR of 8.2 % puts the metrology services ... in 2018, as stated in a Transparency Market Research ... Size, Share, Growth, Trends, and Forecast 2012 – 2018”. ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 For over ... supplier of MadgeTech data logging products to industries in ... equipment and the development of management systems for certification ... service, quality, and technical support. , MadgeTech Inc. ... reach internationally. “We are very pleased to see the ...
(Date:9/17/2014)... NY (PRWEB) September 17, 2014 ... and Access Management (IdM/IAM) solutions and Boston ... announced their business partner relationship. Under ... Systems’ technology to automate functionality within its ... Boston Software Systems provides healthcare automation platforms ...
(Date:9/17/2014)... NJ (PRWEB) September 17, 2014 ... Application Security Testing (SAST) tool, at AppSec USA 2014 ... from 9 am to 6 pm at booth G4 ... one of the leading software security conferences for developers, ... a tool that provides developers and managers with the ...
(Date:9/17/2014)... release is available in Spanish . ... more than half of the population in our Community. ... of which affects liver function. Fat accumulates in the ... inflammation, fibrosis and finally, cirrhosis. To date, the most ... biopsy. Imaging techniques such as abdominal ecography detect it ...
Breaking Medicine News(10 mins):Health News:Metrology Services Market to Hit USD 720.3 Million by 2018: Transparency Market Research 2Health News:Metrology Services Market to Hit USD 720.3 Million by 2018: Transparency Market Research 3Health News:Main Solutions Now Distributing MadgeTech Data Loggers in Bulgaria 2Health News:Tools4ever Partners with Boston Software Systems to Automate Identity and Password Management 2Health News:Tools4ever Partners with Boston Software Systems to Automate Identity and Password Management 3Health News:Tools4ever Partners with Boston Software Systems to Automate Identity and Password Management 4Health News:Fasoo to Introduce Their Testing Tool to Improve Software Security and Quality at AppSec USA 2014 2Health News:Magnetic resonance helps to detect and quantify fat in liver 2
... it has been known that aspirin is beneficial to ... of the many different types of aspirin is likely ... led by Dr. Sean Nordt from the University of ... to a group of volunteer research subjects: regular aspirin ...
... May 15 Endocare, Inc. (Nasdaq: ENDO ... development of minimally invasive technologies used by urologists and ... results for the first quarter ended March 31, 2009. ... increase in revenue and strong margins.Total revenues for the ...
... Dr. Bruno E. Gerber is recognized in ... is a Consultant Orthopedic Surgeon with a special ... of the lower limbs. He also is employed ... development project regarding innovative orthopedic laser treatment.Dr. Gerber ...
... in Steinbach, Manitoba , ... Steinbach, Manitoba, Canada (Vocus) May 15, 2009 ... chronic pain. Even pop singer, famed choreographer, and American Idol judge, Paula ... the May issue of Ladies Home Journal. While Abdul admits to being ...
... influenza epidemic has raised many questions about how animal ... through veterinarians, who, according to a new report by ... at markedly increased risk of infection with zoonotic pathogens ... animals and humans. , While there is no ...
... Hundreds of Albert Lea residents joined together on Thursday ... the AARP(R)/Blue Zones(R) Vitality Project sponsored by United Health ... residents to take charge of their health so that ... leaders have been working behind the scenes with the ...
Cached Medicine News:Health News:Endocare Reports 2009 First Quarter Financial Results 2Health News:Endocare Reports 2009 First Quarter Financial Results 3Health News:Endocare Reports 2009 First Quarter Financial Results 4Health News:Endocare Reports 2009 First Quarter Financial Results 5Health News:Endocare Reports 2009 First Quarter Financial Results 6Health News:Endocare Reports 2009 First Quarter Financial Results 7Health News:Endocare Reports 2009 First Quarter Financial Results 8Health News:Endocare Reports 2009 First Quarter Financial Results 9Health News:Endocare Reports 2009 First Quarter Financial Results 10Health News:Endocare Reports 2009 First Quarter Financial Results 11Health News:Continental Who's Who Executive Press Release: Dr. Bruno E. Gerber - Medical Professional 2Health News:Chronic Pain Sufferers Find Hope in the Darkness 2Health News:Veterinarians at high risk for viral, bacterial infections from animals 2Health News:Veterinarians at high risk for viral, bacterial infections from animals 3Health News:Albert Lea Residents Pledge to Add 10,000 Collective Years of Life to Their City 2Health News:Albert Lea Residents Pledge to Add 10,000 Collective Years of Life to Their City 3Health News:Albert Lea Residents Pledge to Add 10,000 Collective Years of Life to Their City 4Health News:Albert Lea Residents Pledge to Add 10,000 Collective Years of Life to Their City 5
Agility has delivered a RFID-enabled mobile asset management program....
... VerdaSee Location-ID™ is a family of ... equipment and individuals inside hospitals, healthcare ... frequency technology. The target tracking areas ... a series of radio frequency identification ...
The WatchMate LC model is a cost-effective solution for monitoring a single exit, and provides local notification of an alarm....
Assetrac allows identification, location, and protection of your assets....
Medicine Products: